Prelude Therapeutics Incorporated earnings per share and revenue

PRLD earnings per share for the last quarter are -0.43 USD whereas the estimation was -0.47 USD which accounts for 8.90% surprise. Company revenue for the same period amounts to 3.00 M USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -0.47 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of PRLD earnings per share and revenue dynamics.